相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
The lymph node at a glance - how spatial organization optimizes the immune response
Spencer M. Grant et al.
JOURNAL OF CELL SCIENCE (2020)
Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis
Jing Yang et al.
MEDICINE (2020)
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Tyson J. Moyer et al.
NATURE MEDICINE (2020)
Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults
Hillary A. Vanderven et al.
VACCINE (2020)
Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
Fatimah S. Dawood et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway
Eui Ho Kim et al.
ELIFE (2020)
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations
Jacob T. Martin et al.
NPJ VACCINES (2020)
Why and How Vaccines Work
Akiko Iwasaki et al.
CELL (2020)
Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses
Gabriel Kristian Pedersen et al.
FRONTIERS IN IMMUNOLOGY (2020)
Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus
Brenda L. Tesini et al.
JOURNAL OF VIROLOGY (2019)
B Cell Responses: Cell Interaction Dynamics and Decisions
Jason G. Cyster et al.
CELL (2019)
T Follicular Helper Cell Biology: A Decade of Discovery and Diseases
Shane Crotty
IMMUNITY (2019)
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children
Sanjay S. Patel et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Material design for lymph node drug delivery
Alex Schudel et al.
NATURE REVIEWS MATERIALS (2019)
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin
Sarah F. Andrews et al.
IMMUNITY (2019)
An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines
Michael I. Hauser et al.
VACCINE (2019)
Comparison of adjuvants to optimize influenza neutralizing antibody responses
Rebecca S. Rudicell et al.
VACCINE (2019)
Role of Memory B Cells in Hemagglutinin-Specific Antibody Production Following Human Influenza A Virus Infection
Mark Y. Sangster et al.
PATHOGENS (2019)
Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines
Million A. Tegenge et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Subcapsular Sinus Macrophages: The Seat of Innate and Adaptive Memory in Murine Lymph Nodes
Imogen Moran et al.
TRENDS IN IMMUNOLOGY (2019)
Pandemic influenza vaccines: what they have taught us about B cell immunology
David J. Topham et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
A. Danielle Iuliano et al.
LANCET (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage
Davide Angeletti et al.
TRENDS IN IMMUNOLOGY (2018)
From Original Antigenic Sin to the Universal Influenza Virus Vaccine
Carole Henry et al.
TRENDS IN IMMUNOLOGY (2018)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Immunology and efficacy of MF59-adjuvanted vaccines
Eun-Ju Ko et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
Surender Khurana et al.
NPJ VACCINES (2018)
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake
Frank Liang et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Immune history and influenza virus susceptibility
Sarah Cobey et al.
CURRENT OPINION IN VIROLOGY (2017)
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
Daniel Stadlbauer et al.
MSPHERE (2017)
Germinal center enhancement by extended antigen availability
Kimberly M. Cirelli et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Towards an evidence based approach for the development of adjuvanted vaccines
Derek T. O'Hagan et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
Richard K. Zimmerman et al.
CLINICAL INFECTIOUS DISEASES (2016)
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
Hok Hei Tam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood
Helder I. Nakaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Antigen Presentation to B Cells
Balthasar A. Heesters et al.
TRENDS IN IMMUNOLOGY (2016)
Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination
J. D. Galson et al.
SCIENTIFIC REPORTS (2016)
Influenza Vaccines: Challenges and Solutions
Katherine Houser et al.
CELL HOST & MICROBE (2015)
Long-Lived Plasma Cells Are Contained within the CD19-CD38hiCD138+ Subset in Human Bone Marrow
Jessica L. Halliley et al.
IMMUNITY (2015)
Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response A Randomized Clinical Trial
Lisa A. Jackson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life
Beatris Mastelic Gavillet et al.
JOURNAL OF IMMUNOLOGY (2015)
Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine With MF59 Adjuvant A Randomized Clinical Trial
Robert B. Belshe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant A Randomized Clinical Trial
Mark J. Mulligan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
Ali H. Ellebedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
Irina Margine et al.
JOURNAL OF VIROLOGY (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
Maria Vono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
Samuele Calabro et al.
VACCINE (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Antigen depot is not required for alum adjuvanticity
Sharon Hutchison et al.
FASEB JOURNAL (2012)
AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method
Marie-Francoise Klucker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
Gui-Mei Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The mechanism of action of MF59 - An innately attractive adjuvant formulation
D. T. O'Hagan et al.
VACCINE (2012)
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly
Roberto Gasparini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
Philippe Moris et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59
Ali H. Ellebedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
Samuele Calabro et al.
VACCINE (2011)
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
Sandra Morel et al.
VACCINE (2011)
Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant
Jane Baer et al.
VACCINE (2010)
Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response
Stephanie M. Noe et al.
VACCINE (2010)
Emulsion-based adjuvants for influenza vaccines
Frederick R. Vogel et al.
EXPERT REVIEW OF VACCINES (2009)
Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004-2005 Season to the 2006-2007 Season
Edward A. Belongia et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Long-term presence of memory B-cells specific for different vaccine components
A. M. Buisman et al.
VACCINE (2009)
A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses
Benoit Baras et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells
Anja Seubert et al.
JOURNAL OF IMMUNOLOGY (2008)
An adjuvanted, low-dose, pandemic influenza a (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults
Karin Levie et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant
Nega Ali Goji et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Molecular and cellular signatures of human vaccine adjuvants
F. Mosca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses
JM Kemp et al.
VACCINE (2002)
Polymorphonuclear neutrophils as accessory cells for T-cell activation:: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation
M Radsak et al.
IMMUNOLOGY (2000)
分享论文
